Literature DB >> 23536134

Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study.

Daniel W Belsky1, Terrie E Moffitt, Timothy B Baker, Andrea K Biddle, James P Evans, HonaLee Harrington, Renate Houts, Madeline Meier, Karen Sugden, Benjamin Williams, Richie Poulton, Avshalom Caspi.   

Abstract

IMPORTANCE: Genome-wide hypothesis-free discovery methods have identified loci that are associated with heavy smoking in adulthood. Research is needed to understand developmental processes that link newly discovered genetic risks with adult heavy smoking.
OBJECTIVE: To test how genetic risks discovered in genome-wide association studies of adult smoking influence the developmental progression of smoking behavior from initiation through conversion to daily smoking, progression to heavy smoking, nicotine dependence, and struggles with cessation.
DESIGN: A 38-year, prospective, longitudinal study of a representative birth cohort.
SETTING: The Dunedin Multidisciplinary Health and Development Study of New Zealand. PARTICIPANTS: The study included 1037 male and female participants. EXPOSURE: We assessed genetic risk with a multilocus genetic risk score. The genetic risk score was composed of single-nucleotide polymorphisms identified in 3 meta-analyses of genome-wide association studies of smoking quantity phenotypes. MAIN OUTCOMES AND MEASURES: Smoking initiation, conversion to daily smoking, progression to heavy smoking, nicotine dependence (Fagerström Test of Nicotine Dependence), and cessation difficulties were evaluated at 8 assessments spanning the ages of 11 to 38 years.
RESULTS: Genetic risk score was unrelated to smoking initiation. However, individuals at higher genetic risk were more likely to convert to daily smoking as teenagers, progressed more rapidly from smoking initiation to heavy smoking, persisted longer in smoking heavily, developed nicotine dependence more frequently, were more reliant on smoking to cope with stress, and were more likely to fail in their cessation attempts. Further analysis revealed that 2 adolescent developmental phenotypes-early conversion to daily smoking and rapid progression to heavy smoking-mediated associations between the genetic risk score and mature phenotypes of persistent heavy smoking, nicotine dependence, and cessation failure. The genetic risk score predicted smoking risk over and above family history. CONCLUSIONS AND RELEVANCE: Initiatives that disrupt the developmental progression of smoking behavior among adolescents may mitigate genetic risks for developing adult smoking problems. Future genetic research may maximize discovery potential by focusing on smoking behavior soon after smoking initiation and by studying young smokers.

Entities:  

Mesh:

Year:  2013        PMID: 23536134      PMCID: PMC3644004          DOI: 10.1001/jamapsychiatry.2013.736

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  66 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

2.  Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.

Authors:  C Lerman; C Jepson; E P Wileyto; F Patterson; R Schnoll; M Mroziewicz; N Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2010-03-24       Impact factor: 6.875

Review 3.  Community interventions for preventing smoking in young people.

Authors:  Kristin V Carson; Malcolm P Brinn; Nadina A Labiszewski; Adrian J Esterman; Anne B Chang; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

4.  Trends in the genetic influences on smoking.

Authors:  Jason D Boardman; Casey L Blalock; Fred C Pampel
Journal:  J Health Soc Behav       Date:  2010-03

5.  Early smoking onset may promise initial pleasurable sensations and later addiction.

Authors:  Arlette F Buchmann; Dorothea Blomeyer; Christine Jennen-Steinmetz; Martin H Schmidt; Günter Esser; Tobias Banaschewski; Manfred Laucht
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

6.  Chronic disease management for tobacco dependence: a randomized, controlled trial.

Authors:  Anne M Joseph; Steven S Fu; Bruce Lindgren; Alexander J Rothman; Molly Kodl; Harry Lando; Brandon Doyle; Dorothy Hatsukami
Journal:  Arch Intern Med       Date:  2011-11-28

7.  Population composition, public policy, and the genetics of smoking.

Authors:  Jason D Boardman; Casey L Blalock; Fred C Pampel; Peter K Hatemi; Andrew C Heath; Lindon J Eaves
Journal:  Demography       Date:  2011-11

Review 8.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

9.  Developmental perspective on the role of genes in smoking risk.

Authors:  Joel Gelernter
Journal:  Biol Psychiatry       Date:  2011-04-01       Impact factor: 13.382

10.  Meta-analysis and imputation refines the association of 15q25 with smoking quantity.

Authors:  Jason Z Liu; Federica Tozzi; Dawn M Waterworth; Sreekumar G Pillai; Pierandrea Muglia; Lefkos Middleton; Wade Berrettini; Christopher W Knouff; Xin Yuan; Gérard Waeber; Peter Vollenweider; Martin Preisig; Nicholas J Wareham; Jing Hua Zhao; Ruth J F Loos; Inês Barroso; Kay-Tee Khaw; Scott Grundy; Philip Barter; Robert Mahley; Antero Kesaniemi; Ruth McPherson; John B Vincent; John Strauss; James L Kennedy; Anne Farmer; Peter McGuffin; Richard Day; Keith Matthews; Per Bakke; Amund Gulsvik; Susanne Lucae; Marcus Ising; Tanja Brueckl; Sonja Horstmann; H-Erich Wichmann; Rajesh Rawal; Norbert Dahmen; Claudia Lamina; Ozren Polasek; Lina Zgaga; Jennifer Huffman; Susan Campbell; Jaspal Kooner; John C Chambers; Mary Susan Burnett; Joseph M Devaney; Augusto D Pichard; Kenneth M Kent; Lowell Satler; Joseph M Lindsay; Ron Waksman; Stephen Epstein; James F Wilson; Sarah H Wild; Harry Campbell; Veronique Vitart; Muredach P Reilly; Mingyao Li; Liming Qu; Robert Wilensky; William Matthai; Hakon H Hakonarson; Daniel J Rader; Andre Franke; Michael Wittig; Arne Schäfer; Manuela Uda; Antonio Terracciano; Xiangjun Xiao; Fabio Busonero; Paul Scheet; David Schlessinger; David St Clair; Dan Rujescu; Gonçalo R Abecasis; Hans Jörgen Grabe; Alexander Teumer; Henry Völzke; Astrid Petersmann; Ulrich John; Igor Rudan; Caroline Hayward; Alan F Wright; Ivana Kolcic; Benjamin J Wright; John R Thompson; Anthony J Balmforth; Alistair S Hall; Nilesh J Samani; Carl A Anderson; Tariq Ahmad; Christopher G Mathew; Miles Parkes; Jack Satsangi; Mark Caulfield; Patricia B Munroe; Martin Farrall; Anna Dominiczak; Jane Worthington; Wendy Thomson; Steve Eyre; Anne Barton; Vincent Mooser; Clyde Francks; Jonathan Marchini
Journal:  Nat Genet       Date:  2010-04-25       Impact factor: 38.330

View more
  67 in total

Review 1.  A guide on gene prioritization in studies of psychiatric disorders.

Authors:  Sven Stringer; Kim C Cerrone; Wim van den Brink; Julia F van den Berg; Damiaan Denys; Rene S Kahn; Eske M Derks
Journal:  Int J Methods Psychiatr Res       Date:  2015-07-31       Impact factor: 4.035

2.  Nondaily, Low-Rate Daily, and High-Rate Daily Smoking in Young Adults: A 17-Year Follow-Up.

Authors:  Lindsay Robertson; Ella Iosua; Rob McGee; Robert J Hancox
Journal:  Nicotine Tob Res       Date:  2015-08-05       Impact factor: 4.244

3.  Developmental mediation of genetic variation in response to the Fast Track prevention program.

Authors:  Dustin Albert; Daniel W Belsky; D Max Crowley; John E Bates; Gregory S Pettit; Jennifer E Lansford; Danielle Dick; Kenneth A Dodge
Journal:  Dev Psychopathol       Date:  2015-02

4.  Genetics and the geography of health, behaviour and attainment.

Authors:  Daniel W Belsky; Avshalom Caspi; Louise Arseneault; David L Corcoran; Benjamin W Domingue; Kathleen Mullan Harris; Renate M Houts; Jonathan S Mill; Terrie E Moffitt; Joseph Prinz; Karen Sugden; Jasmin Wertz; Benjamin Williams; Candice L Odgers
Journal:  Nat Hum Behav       Date:  2019-04-08

5.  Are addictions diseases or choices?

Authors:  Marco Leyton
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

6.  An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High School.

Authors:  David J Vandenbergh; Gabriel L Schlomer; H Harrington Cleveland; Alisa E Schink; Kerry L Hair; Mark E Feinberg; Jenae M Neiderhiser; Mark T Greenberg; Richard L Spoth; Cleve Redmond
Journal:  Nicotine Tob Res       Date:  2015-05-04       Impact factor: 4.244

7.  The 2016 Ferno Award Address: Three Things.

Authors:  Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2017-08-01       Impact factor: 4.244

Review 8.  The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research.

Authors:  Conrad Iyegbe; Desmond Campbell; Amy Butler; Olesya Ajnakina; Pak Sham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-17       Impact factor: 4.328

9.  Rare nonsynonymous exonic variants in addiction and behavioral disinhibition.

Authors:  Scott I Vrieze; Shuang Feng; Michael B Miller; Brian M Hicks; Nathan Pankratz; Gonçalo R Abecasis; William G Iacono; Matt McGue
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

10.  Progression of nicotine dependence, mood level, and mood variability in adolescent smokers.

Authors:  Thomas M Piasecki; Donald Hedeker; Lisa C Dierker; Robin J Mermelstein
Journal:  Psychol Addict Behav       Date:  2016-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.